Apellis Pharmaceuticals, Inc. - APLS
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$12.95M
QoQ value delta ($000)
-$5.627B
(-99.77%)
Implied price effect (QoQ)
+1.55%
Shares
Total shares
322,031
QoQ shares delta
-142,080,052
(-99.77%)
Total shares held by funds (by quarter)
Market chart (APLS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10,143 | 252,130 | 0.0% |
| CIBRA Capital Ltd | 2,011 | 50,000 | 0.97% |
| CWM, LLC | 458 | 11,403 | 0.0% |
| BCK CAPITAL MANAGEMENT LP | 321 | 8,000 | 1.4% |
| IFP Advisors, Inc | 10 | 248 | 0.0% |
| Evelyn Partners Investment Management LLP | 6 | 150 | 0.0% |
| Financial Gravity Asset Management, Inc. | 4 | 100 | 0.0% |